Healthcare >> CEO Interviews >> September 13, 2002
R. FORREST WALDON Esq. is Chairman, President and CEO of Endeavor
Pharmaceuticals, Inc. He has served as Chairman of the Board since
February 2000 and as President and Chief Executive Officer since March
1999. Before joining Endeavor, Mr. Waldon held several management
positions at aaiPharma, a specialty pharmaceutical company. At
aaiPharma, Mr. Waldon served as Executive Vice President from May 1997
through 1998, General Counsel and Secretary from 1989 through 1998, and
Vice President from 1993 through 1997. Prior to his employment with
aaiPharma, Mr. Waldon practiced law with Thrasher & Whitley, P.C. in
Atlanta, Georgia. Mr. Waldon received his B.S. from the University of
North Carolina at Chapel Hill, Phi Beta Kappa, where he also received
his J.D. Profile
TWST: Could you give us a little of the history of EndeavorPharmaceuticals and then bring us down to some of the very interesting
recent events regarding your IPO filing, etc.?
Mr. Waldon: